PPHM Opinions 08/11/2014 22:37:08

New Post Public Reply Private Reply Replies (0) Message Board
Jake13
PPHM Opinions 08/11/2014 22:37:08 $PPHM
Quote:
Peregrine's made it this far, they might as well try to get it done alone. If we can squeak by in NSCLC then it opens Pandora's box.


That was a post from another respected poster in a PM weeks ago....


Looks like Pandoras box is starting to BULGE.....and I believe that squeak is going to be THUNDEROUS.

; )


wook
Yes well respected poster who's stance on PPHM is well documented, whose name I will not mention for wookies especially fear being accused of something so terrible that wookie will be gone.

That is a great comparison of PPHMs and a potential partners situation.....alas....as Billy Idol might say....OH OH....talking with myselElf oh oh, oh oh.......

It's shameful that a little control comes to this. Be careful.

I believe WE may have a dual partnership....bidding war or more brewing.
It's a big BIG World...let's hope Bavituximab and Peregrine have it covered.

imho

wook


w......Please announce no PPHM news again tomorrow!: )

Too funny.

Did we even hear that again from the "real" 8AM poster?????

Too bad so sad.

wook
Guess we will find out in approx 60 days if they applied and subsequently approved
Hey if they can fund one and partner the other that's fine with me. A little clarity on direction would be helpful to investors
Why not do both? But I agree, it's time we start getting some clear direction from management. Lock into a partnership or multiple partnerships and maybe we get better communication.

Where did the anti-PPHM crowd go? Ignore function doesn't block them all. You would think they would post something just to plead ignorance when the SEC boys come knocking.
good question on what this will do... or possibly do... to the Phase III lung.

I think that the DMC members live and die on statistics and probabilities and use "ALL" information at hand in any problem. Their current problem.... is sitting on the SunrRise Phase III trial of Peregrines and "if" new inputs are available to them to help them make their decision, then I'm certain they must use all available data.

IF during a clinical trial they find that all persons that pass on ... are all of a sudden found to have a "specific" DNA trait... then they may stop the trial because now the trial may be enrolling patients that are put at risk.

IF the DMC find new information regarding MDSC's or some other form of blood test that proves their immune system is performing optimally and they all happen to be on the Bavi arm of the trial.... ??

Well... I think they can stock the trial right at this point.

Peregrine just may see some intercept type (market cap) price spikes
Fingers crossed.
Wish I knew,

From my conversation last spring heard about biomarkers in liver and melanoma but was told that the lung trial was a straight one without them. Now that was last March and in this spinning world things seem to be changing quite rapidly.
What will this do to lung?
Quote:
now you need to think whether you move forward with that combo or advance the recent anti pd1 preclinical to phase I human trials


... with Pvalues of .004 that is 100% BTD from the FDA, which moves us right into Phase III

I'll agree with Sulaco... "Peregrine sitting in the cat bird seat.." is how I think he worded it
North.... I hope this means that my #1 hope of having CALICO involved with Peregrine is still alive ??

hmmm, maybe so after seeing that shade of green they used on their website.... looks awfully like that shade of green from Peregrines website lol : )

No, not serious about the green shade.... but after seeing green grass grow faster than Peregrines news cycle, one can get anxious

Big Pharma more anxious though and they don't like seeing all these combos coming out, especially with Pvalues of .004

My math friends who I told about Peregrine many months ago seen this today to call and say this is getting interesting now

Math is universal and they see a big, bright future in Tustin, CA

Big Pharma has hid behind Pvalues for many years... and now, its Pvalues that will unleash Peregrine as the top dog
We have phase II with taxane chemo in breast now you need to think whether you move forward with that combo or advance the recent anti pd1 preclinical to phase I human trials. Need better direction from leadership.
SW...you know THEY will try.....PG missed it.....DAD GUM!!!!

Send in PM.....

I'm all the place and really need to catch up on PPHMs' interesting news.

sheesh...where's my wookie copier...I need another one of me! LOL (NOT) 'sigh' yawn.....zzzzzzzzzz


wook
You know I was joking right dude?
Congrats brother porkchop!!!!! Bring the ship around.....I need a ride to the SS Thorpe......time to start prepping the ship.....Again......PPHM may be about to fuel her up with some serious hopium!!!!!

The trend will be our friend again.....just a month and half late. : ) imho


wook
Great PPHM can't even buy their own shares, how amusing lolz
That bodes well for your Kyoto projection IMO.
Here's some biomarkers from pr...

Quote:
Also, the once weekly combination treatment with ch1N11 and anti-PD-1 led to a 78% and 81% increase in intratumoral CD4+ and CD8+ T cells, two key indicators that show that tumor fighting immune cells are present in the local tumor environment, compared to the single agent anti-PD-1.


Local environment.

Got me another 1k today, early.

Imo.

porkchop11 :0
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cooper's Stock Takes a Beating: What's Behind It?

Updated Category News Views 61

A Shock to the System: Cooper's Rough Patch Not every day you see a stock take a body slam like this! Cooper Companies (NASDAQ: COO) got walloped after revealing some unsavory truths about its Q3 2026 performance. The market didn't just flinch—it reeled. On September 10, 2026, COO shares dove a steep $9.31—around a 14.6% free fall—whacking off over $1.7 billion in...

Continue Reading
WesternU's Big Night: Boosting Lebanon’s Health Hub

Updated Category News Views 64

Building Bridges in Healthcare: WesternU's Strategic Move Heck, you know it's the real deal when a university throws a dinner party to celebrate partnerships. Western University of Health Sciences (WesternU) decided to clink glasses with Lebanon community leaders, hammering home the importance of their collaboration on October 6, 2026. Now, don't think this was just some...

Continue Reading
Visionary Animator Julian Glander to Speak at RMCAD

Updated Category News Views 63

Art Meets Animation: Glander's Inspiring Visit In the offbeat, winding world of creativity, Julian Glander's name rings some serious bells. This Pittsburgh-based powerhouse, known for his whimsical animations and illustrations, is heading to Rocky Mountain College of Art + Design (RMCAD) for the 2026/2027 Friction Series. It's happening November 10—pencil that in...

Continue Reading
24 Hour Fitness Pioneers New Club in Growing Summerlin

Updated Category News Views 66

The Next Era of Fitness in Las Vegas Well, color me intrigued. Mark Mastrov, that pioneer behind 24 Hour Fitness, has got a new trick up his sleeve—and it's not your run-of-the-mill gym. Summerlin, Las Vegas will soon house the Founders Club, a beast of a fitness facility sprawling over 45,000 square feet. Talk about bringing big energy to a place that's already...

Continue Reading
Co-op Giants Earn $309B: Key Players Spotlighted

Updated Category News Views 223

Co-ops Punch Above Their Weight Forget the tired stereotypes about co-ops as small-time players. The NCB Co-op 100® Report lands like a punch with a staggering revelation: $309 billion in revenue for 2025. That's no small potatoes, and it shows these cooperatives, sprinkled across agriculture, finance, and beyond, are no shy creatures—they're major contenders in...

Continue Reading
Tampa General Elevates Lokenauth to CFO Amid Growth

Updated Category News Views 69

Charting New Waters at Tampa General Out here in the blue, the tides of healthcare can swell mighty quick. That's where Tampa General Hospital keeps its anchor firm, announcing Lijah Lokenauth's leap to Executive VP and CFO. If you ask me, it's all about keeping the ship steady—this fella's been steering their financial boat through some hefty waves since 2018....

Continue Reading
UBCF & GGP Join Forces for Nationwide Pink Bag Drive

Updated Category News Views 23

Caring Through Community: Pink Bag Events Unroll What do you get when compassion meets action? That's the story with the United Breast Cancer Foundation (UBCF) and GGP's Pink Bag Event. Here in 2026, these folks are doing something so damn important, you'd wonder why more don’t follow suit. For the fifth straight year, they're rolling out a campaign that bridges the gap...

Continue Reading
Ensign Lawsuit Deadline Looms: Investors, Wake Up!

Updated Category News Views 27

A Storm Brewing in Healthcare Here's what will make any half-savvy investor's pulse quicken: The Ensign Group, Inc. (NasdaqGS: ENSG) is in hot legal water, and there's a hefty class action floating around with some serious allegations. ClaimsFiler's got the word out, marking December 7, 2026, as the cut-off date for investors wanting to be part of this securities class...

Continue Reading
Urgent Deadline Looms for Hims Class Action Investors

Updated Category News Views 136

Hims & Hers Under Fire: Act Now or Pay Later If you're holding $HIMS shares, let me tell you—this isn't the time to snooze. With a federal lawsuit breathing down its neck, Hims & Hers Health, Inc. finds itself teetering on the precipice of serious financial and legal mayhem. The clock's ticking with the class action cutoff looming on November 2, 2026. If you're nursing...

Continue Reading
FuelCell's Legal Storm Over Misleading Disclosures

Updated Category News Views 82

The Hard Sell on FuelCell's Promises FuelCell Energy, folks. If you've been anywhere near the market scene, you know their tale: promising clean energy with a side of misery for investors. Right now, the company finds itself in hot water over some murky disclosures about its business prowess—or lack thereof. A class action suit is brewing, and anyone with money tied up...

Continue Reading

Top 5 Most Recently Viewed Articles

Vigil Neuroscience Takes Major Steps at Upcoming Biotech Event

Updated Category News Views 93

A Major Presentation by Vigil Neuroscience Vigil Neuroscience, a clinical-stage biotechnology firm dedicated to advancing treatments for neurodegenerative diseases, has announced its participation in a significant industry event. This will be at the Guggenheim Securities SMID Cap Biotech Conference, where management will engage in a fireside chat. This opportunity offers...

Continue Reading
Zone 5 Technologies Enhances ETV with Advanced Software Solutions

Updated Category News Views 399

Zone 5 Technologies Enhances ETV with Advanced Software Solutions Zone 5 Technologies has made a significant leap in innovation by selecting Scientific Systems and its Collaborative Weapon Autonomy (CWA) software suite for integration into its Enterprise Test Vehicle (ETV) prototypes. This choice marks an exciting new chapter for Zone 5 as it aims to develop low-cost,...

Continue Reading
Volkswagen and Google Team Up for Innovative AI Assistant

Updated Category News Views 282

Introduction to the Collaboration The partnership between Volkswagen and Google represents a major step forward in bringing artificial intelligence into everyday driving experiences. By leveraging its well-known cloud services and AI capabilities, Google aims to enhance the functionality available to Volkswagen drivers. Features of the AI Assistant Volkswagen’s...

Continue Reading
KBRA Confirms AA- Rating for Triborough Authority's Revenue Bonds

Updated Category News Views 288

KBRA Assigns AA- Rating to Triborough Authority Bonds KBRA has recently assigned a long-term rating of AA- to the Triborough Bridge and Tunnel Authority (TBTA) Subordinate Revenue Bond Anticipation Notes, Series 2025A. This rating comes with a stable outlook and underscores the significance of TBTA as a critical element in the transportation infrastructure serving the New...

Continue Reading
Durability & Cost: Asphalt Shingles vs Metal Roofing

Updated Category News Views 12

Choosing the Right Roof: Beyond the Basics Every homeowner in North Carolina has found themselves standing in that indecisive spot, toggling between asphalt shingles and metal roofs. This isn't just about aesthetics or trends; it's a decisive move that will shape your home's future against North Carolina's unpredictable weather. Cutler Creed, the president of Creed &...

Continue Reading